Medical Procedures and Risk for Sporadic Creutzfeldt-Jakob Disease, Japan, 1999–2008
Tsuyoshi Hamaguchi, Moeko Noguchi-Shinohara, Ichiro Nozaki, Yosikazu Nakamura, Takeshi Sato, Tetsuyuki Kitamoto, Hidehiro Mizusawa, and Masahito Yamada
Author affiliations: Kanazawa University Graduate School of Medical Science, Kanazawa, Japan (T. Hamaguchi, M. Noguchi-Shinohara, I. Nozaki, M. Yamada); Jichi Medical University, Shimotsuke, Japan (Y. Nakamura); Kohnodai Hospital, Ichikawa, Japan (T. Sato); Tohoku University Graduate School of Medicine, Sendai, Japan (T. Kitamoto); Tokyo Medical and Dental University, Tokyo, Japan (H. Mizusawa); Creutzfeldt-Jakob Disease Surveillance Committee, Japan (Y. Nakamura, T. Sato, J. Mizusawa, T. Kitamoto, M. Yamada)
Main Article
Table 7
Data for sCJD patients who had ophthalmic surgery for cataracts after onset of sCJD symptoms, Japan, 1999–2008*
Patient no. |
Interval between onset of sCJD symptoms and surgery, mo |
Age at onset of sCJD, y |
Symptom at onset of sCJD |
1 |
0 |
60 |
Gait disturbance |
2 |
0 |
61 |
Dementia |
3 |
0 |
63 |
Visual impairment |
4 |
0 |
71 |
Visual impairment |
5 |
0 |
74 |
Visual impairment |
6 |
0 |
74 |
Visual impairment |
7 |
1 |
66 |
Dementia |
8 |
1 |
74 |
Depression |
9 |
1 |
85 |
Visual impairment |
10 |
2 |
79 |
Tremor |
11 |
4 |
81 |
Visual impairment |
12 |
8 |
77 |
Anxiety |
13 |
10 |
57 |
Dementia |
14 |
14 |
64 |
Visual impairment |
Main Article
Page created: December 08, 2010
Page updated: December 08, 2010
Page reviewed: December 08, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.